EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Quality by Design (QbD) Project of Human Dermal Fibroblast and its Therapeutic Effects on Managing Degenerative Intervertebral Disc Fibrosis in Rabbit and Cynomolgus Monkey

Li Zhou, Hongsheng Li, Chen Chen, Hao Yang, Guicheng Zhang, Qin Zhang, Mengnan Wen, Lei Shi, Tong Xing, Ming Fan, An Qin, Jie Zhao und 1 weitere

Frontiers in Bioscience-Landmark · 2025

DOI: 10.31083/fbl28062 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2025. Verfasst von Li Zhou und 12 weiteren Autor:innen. Beteiligte Einrichtung: FibroX Therapeutics (Shanghai) Inc., 201203 Shanghai, China. Hauptthemen laut MEDLINE: Fibroblasts, Intervertebral Disc Degeneration. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FibroX Therapeutics (Shanghai) Inc..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Low back pain (LBP) is the leading cause of disability among the elderly, placing significant social and economic burdens on societies globally. A common cause of chronic LBP is lumbar disc degeneration. Previously, we reported that autologous or allogenic fibroblast injections could treat intervertebral disc degeneration (IVDD) in preclinical studies by maintaining disc height and stability through fibrosis. However, the pathway to successful drug development remains unclear.

Methods

To develop a novel human allogenic fibroblast injection, we launched a quality-by-design (QbD) project focusing on human dermal fibroblasts (HDFs).

Results

We developed a tissue separation process, HDF culture process, and HDF cryopreservation process. The tissue disinfection method used 5% povidone-iodine solution and 75% alcohol for 3–5 min each; the tissue digestion conditions used neutral protease AF followed by overnight soaking plus collagenase NB6 digestion for 2–3 h; the non-animal component medium contained high glucose dulbecco’s modified eagle medium (DMEM) + 7.5% human platelet lysate (hPL); A cell density of 14,000–18,000 cells/cm2 was used; the cell cryopreservation solution contained 75% CS10 + 10% human serum albumin (HSA) + 15% saline (NaCl). Finally, we explored its therapeutic effects by treating IVDD in rabbits.

Conclusions

The model of lumbar disc degeneration in rabbits was induced by acupuncture, and HDF was injected into the intervertebral disc. The therapeutic effect of HDF was observed by imaging and histopathology at 1, 3, and 6 months after administration. HDF treatment significantly improved the water content of degenerative intervertebral discs and maintained the height and stability of intervertebral discs. Signal pathway analysis in cynomolgus monkeys suggested that the primary mechanism involves promoting disc fibrosis. Therefore, this study demonstrated the feasibility and cost-effectiveness of manufacturing FibroCellTM, a foreskin-derived human dermal fibroblast injection. FibroCellTM shows promise as a cell-based therapy for IVDD treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibroblastsIntervertebral Disc DegenerationAnimalsRabbitsMacaca fascicularisHumansFibrosisCryopreservationDisease Models, AnimalMaleCells, CulturedDermisIntervertebral Disc

Stichwörter der Autor:innen

cell therapyhuman dermal fibroblasts (HDFs)intervertebral disc degeneration (IVDD)low lack painlumbar/intervertebral disc (IVD)

Autor:innen und Institutionen

  • FibroX Therapeutics (Shanghai) Inc., 201203 Shanghai, China.
  • Shanghai Key Laboratory of Orthopaedic Implants, Department of Orthopaedic Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, 200011 Shanghai, China.
  • Shanghai Jiao Tong University School of Medicine, 200025 Shanghai, China.

Förderung

  • FibroX Therapeutics (Shanghai) Inc.

Zitieren

APA

Zhou, L., Li, H., Chen, C., Yang, H., Zhang, G., Zhang, Q., Wen, M., Shi, L., Xing, T., Fan, M., Qin, A., Zhao, J., & Zhou, S. (2025). A Quality by Design (QbD) Project of Human Dermal Fibroblast and its Therapeutic Effects on Managing Degenerative Intervertebral Disc Fibrosis in Rabbit and Cynomolgus Monkey. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl28062

Vancouver

Zhou L, Li H, Chen C, Yang H, Zhang G, Zhang Q, et al. A Quality by Design (QbD) Project of Human Dermal Fibroblast and its Therapeutic Effects on Managing Degenerative Intervertebral Disc Fibrosis in Rabbit and Cynomolgus Monkey. Frontiers in Bioscience-Landmark. 2025. doi:10.31083/fbl28062

BibTeX
@article{Zhou2025,
  author = {Zhou, Li and Li, Hongsheng and Chen, Chen and Yang, Hao and Zhang, Guicheng and Zhang, Qin and Wen, Mengnan and Shi, Lei and Xing, Tong and Fan, Ming and Qin, An and Zhao, Jie and Zhou, Shen'ao},
  title = {A Quality by Design (QbD) Project of Human Dermal Fibroblast and its Therapeutic Effects on Managing Degenerative Intervertebral Disc Fibrosis in Rabbit and Cynomolgus Monkey},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2025},
  doi = {10.31083/fbl28062}
}
Kostenlos starten →